Page last updated: 2024-08-25

bendamustine hydrochloride and DDD MPGNII

bendamustine hydrochloride has been researched along with DDD MPGNII in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartel, C; Geiger, H; Hauser, IA; Obermüller, N; Rummel, MJ1

Other Studies

1 other study(ies) available for bendamustine hydrochloride and DDD MPGNII

ArticleYear
Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.
    Clinical nephrology, 2008, Volume: 69, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Humans; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nephrotic Syndrome; Nitrogen Mustard Compounds; Remission Induction; Rituximab

2008